PhRMA: ‘Butterfly Effect’ of Poor Legislative Policy Affecting Regulations, Patients

PhRMA is concerned about the effect of the current government shutdown and federal budget cuts known as sequestration on the ability of the FDA to fulfill its mission.
Regulatory Focus